Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Feasibility of Non-invasive Fetal Electrocardiographic Interval Measurement in the Outpatient Clinical Setting.

Doshi AN, Mass P, Cleary KR, Moak JP, Funamoto K, Kimura Y, Khandoker AH, Krishnan A.

Pediatr Cardiol. 2019 Jun 6. doi: 10.1007/s00246-019-02128-w. [Epub ahead of print]

PMID:
31172229
2.

Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.

Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA.

J Clin Oncol. 2008 Jul 20;26(21):3496-502. doi: 10.1200/JCO.2007.15.8634.

PMID:
18640930
3.

Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies.

Ross WA, Ghosh S, Dekovich AA, Liu S, Ayers GD, Cleary KR, Lee JH, Couriel D.

Am J Gastroenterol. 2008 Apr;103(4):982-9. Epub 2007 Nov 19.

PMID:
18028511
4.

The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation.

Wang KL, Yang Q, Cleary KR, Swisher SG, Correa AM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT.

Cancer. 2006 Oct 1;107(7):1467-74.

5.

Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.

Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB.

Ann Surg Oncol. 2006 Apr;13(4):582-94. Epub 2006 Mar 7.

PMID:
16523362
6.

Intraoperative image processing for surgical guidance.

Aylward SR, Cleary KR, Hawkes DJ.

IEEE Trans Med Imaging. 2005 Nov;24(11):1401-4. No abstract available.

PMID:
16279077
7.

Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer.

Pawlik TM, Abdalla EK, Barnett CC, Ahmad SA, Cleary KR, Vauthey JN, Lee JE, Evans DB, Pisters PW.

Arch Surg. 2005 Jun;140(6):584-9; discussion 589-91.

PMID:
15967906
8.

Sarcoidosis after surgically induced remission of Cushing's disease.

Maldonado M, Orlander P, Roshan SY, McCutcheon IE, Cleary KR, Friend KE.

Endocr Pract. 1999 Jan-Feb;5(1):43-5.

PMID:
15251702
9.

Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen.

Yang Q, Cleary KR, Yao JC, Swisher SG, Roth JA, Lynch PM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT.

Dis Esophagus. 2004;17(1):38-43.

PMID:
15209739
10.

A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping.

Patten LC, Berger DH, Rodriguez-Bigas M, Mansfield P, Delpassand E, Cleary KR, Fagan SP, Curley SA, Hunt KK, Feig BW.

Cancer. 2004 May 15;100(10):2104-9.

11.

Detection of small pancreatic tumors with multiphasic helical CT.

Bronstein YL, Loyer EM, Kaur H, Choi H, David C, DuBrow RA, Broemeling LD, Cleary KR, Charnsangavej C.

AJR Am J Roentgenol. 2004 Mar;182(3):619-23.

PMID:
14975959
12.

Subaquatic laparoscopy for staging of intraabdominal malignancy.

Abdalla EK, Barnett CC, Pisters PW, Cleary KR, Evans DB, Feig BW, Mansfield PF.

J Am Coll Surg. 2003 Jan;196(1):155-8. No abstract available.

PMID:
12517569
13.

Increased apoptosis in metastatic human colonic adenocarcinomas.

Termuhlen PM, Sweeney-Gotsch BM, Berman RS, Ellis LM, Bucana C, Shen Y, Cleary KR, McConkey DJ.

Cancer Biol Ther. 2002 Jan-Feb;1(1):58-63.

PMID:
12170764
14.

Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome.

Pisters PW, Wolff RA, Janjan NA, Cleary KR, Charnsangavej C, Crane CN, Lenzi R, Vauthey JN, Lee JE, Abbruzzese JL, Evans DB.

J Clin Oncol. 2002 May 15;20(10):2537-44.

PMID:
12011133
15.

Simplified staging for hepatocellular carcinoma.

Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A, Cleary KR, Nagorney DM.

J Clin Oncol. 2002 Mar 15;20(6):1527-36.

PMID:
11896101
16.

Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index.

Lauwers GY, Terris B, Balis UJ, Batts KP, Regimbeau JM, Chang Y, Graeme-Cook F, Yamabe H, Ikai I, Cleary KR, Fujita S, Flejou JF, Zukerberg LR, Nagorney DM, Belghiti J, Yamaoka Y, Vauthey JN; International Cooperative Study Group on Hepatocellular Carcinoma.

Am J Surg Pathol. 2002 Jan;26(1):25-34.

PMID:
11756766
17.

Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma.

Kuniyasu H, Abbruzzese JL, Cleary KR, Fidler IJ.

Int J Oncol. 2001 Oct;19(4):681-5.

PMID:
11562741
18.

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.

Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JE, Pisters PW, Evans DB.

Ann Surg Oncol. 2001 Mar;8(2):123-32.

PMID:
11258776
19.

Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer.

Hoff PM, Janjan N, Saad ED, Skibber J, Crane C, Lassere Y, Cleary KR, Benner S, Randolph J, Abbruzzese JL, Pazdur R.

J Clin Oncol. 2000 Oct 15;18(20):3529-34.

PMID:
11032595
20.

Human pancreatic ribonuclease 1: expression and distribution in pancreatic adenocarcinoma.

Peracaula R, Cleary KR, Lorenzo J, de Llorens R, Frazier ML.

Cancer. 2000 Sep 15;89(6):1252-8.

PMID:
11002220
21.

Prognostic factors in resectable pancreatic cancer: p53 and bcl-2.

Bold RJ, Hess KR, Pearson AS, Grau AM, Sinicrope FA, Jennings M, McConkey DJ, Bucana CD, Cleary KR, Hallin PA, Chiao PJ, Abbruzzese JL, Evans DB.

J Gastrointest Surg. 1999 May-Jun;3(3):263-77.

PMID:
10481119
22.

Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis.

Bold RJ, Charnsangavej C, Cleary KR, Jennings M, Madray A, Leach SD, Abbruzzese JL, Pisters PW, Lee JE, Evans DB.

J Gastrointest Surg. 1999 May-Jun;3(3):233-43.

PMID:
10481116
23.

Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience.

Janjan NA, Khoo VS, Abbruzzese J, Pazdur R, Dubrow R, Cleary KR, Allen PK, Lynch PM, Glober G, Wolff R, Rich TA, Skibber J.

Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1027-38.

PMID:
10421535
24.

Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers.

Sinicrope FA, Lemoine M, Xi L, Lynch PM, Cleary KR, Shen Y, Frazier ML.

Gastroenterology. 1999 Aug;117(2):350-8.

PMID:
10419916
25.

Expression of interferon-beta is associated with growth arrest of murine and human epidermal cells.

Bielenberg DR, McCarty MF, Bucana CD, Yuspa SH, Morgan D, Arbeit JM, Ellis LM, Cleary KR, Fidler IJ.

J Invest Dermatol. 1999 May;112(5):802-9.

26.

Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer.

Frazier ML, Sinicrope FA, Amos CI, Cleary KR, Lynch PM, Levin B, Luthra R.

Oncol Rep. 1999 May-Jun;6(3):497-505.

PMID:
10203581
27.

Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum.

Bouvet M, Milas M, Giacco GG, Cleary KR, Janjan NA, Skibber JM.

Ann Surg Oncol. 1999 Jan-Feb;6(1):26-32.

PMID:
10030412
28.

The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.

Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ.

Clin Cancer Res. 1999 Jan;5(1):119-27.

29.

Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma.

Kuniyasu H, Ellis LM, Evans DB, Abbruzzese JL, Fenoglio CJ, Bucana CD, Cleary KR, Tahara E, Fidler IJ.

Clin Cancer Res. 1999 Jan;5(1):25-33.

30.

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.

Pisters PW, Abbruzzese JL, Janjan NA, Cleary KR, Charnsangavej C, Goswitz MS, Rich TA, Raijman I, Wolff RA, Lenzi R, Lee JE, Evans DB.

J Clin Oncol. 1998 Dec;16(12):3843-50.

PMID:
9850029
31.

p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.

Spitz FR, Giacco GG, Hess K, Larry L, Rich TA, Janjan N, Cleary KR, Skibber JM.

Clin Cancer Res. 1997 Oct;3(10):1685-90.

32.

Experience implementing a DICOM 3.0 multivendor teleradiology network.

Levine BA, Cleary KR, Norton GS, Mun SK.

Telemed J. 1998 Summer;4(2):167-75.

PMID:
9710649
33.

Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.

Leach SD, Lee JE, Charnsangavej C, Cleary KR, Lowy AM, Fenoglio CJ, Pisters PW, Evans DB.

Br J Surg. 1998 May;85(5):611-7.

PMID:
9635805
34.

Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma.

Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB.

Eur J Cancer. 1998 Feb;34(3):337-40.

PMID:
9640218
35.

Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer.

Takahashi Y, Bucana CD, Akagi Y, Liu W, Cleary KR, Mai M, Ellis LM.

Clin Cancer Res. 1998 Feb;4(2):429-34.

36.

p53, vessel count, and vascular endothelial growth factor expression in human colon cancer.

Takahashi Y, Bucana CD, Cleary KR, Ellis LM.

Int J Cancer. 1998 Feb 20;79(1):34-8.

37.

Overexpression of elongation factor-1gamma protein in colorectal carcinoma.

Mathur S, Cleary KR, Inamdar N, Kim YH, Steck P, Frazier ML.

Cancer. 1998 Mar 1;82(5):816-21.

PMID:
9486568
38.

Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma.

McMasters KM, Tuttle TM, Leach SD, Rich T, Cleary KR, Evans DB, Curley SA.

Am J Surg. 1997 Dec;174(6):605-8; discussion 608-9.

PMID:
9409582
39.
40.

An unusual metastasis to the thumb in a laryngectomized tracheoesophageal speaker.

Lewin JS, Cleary KR, Eicher SA.

Arch Otolaryngol Head Neck Surg. 1997 Sep;123(9):1007-9.

PMID:
9305256
41.

Small cell undifferentiated carcinoma of the pancreas.

Ordóñez NG, Cleary KR, Mackay B.

Ultrastruct Pathol. 1997 Sep-Oct;21(5):467-74.

PMID:
9273978
42.

Solid and papillary tumor of the pancreas: ultrastructural observations on two contrasting cases.

de la Roza G, Cleary KR, Ordóñez NG, el-Naggar A, Mackay B, Romsdahl MM.

Ultrastruct Pathol. 1997 Sep-Oct;21(5):439-47.

PMID:
9273974
43.

Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer.

Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR, Ellis LM.

Arch Surg. 1997 May;132(5):541-6.

PMID:
9161399
44.

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.

Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, Cleary KR, Janjan NA, Goswitz MS, Rich TA, Evans DB.

J Clin Oncol. 1997 Mar;15(3):928-37. Review.

PMID:
9060530
45.

bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.

Sinicrope FA, Evans DB, Leach SD, Cleary KR, Fenoglio CJ, Lee JJ, Abbruzzese JL.

Clin Cancer Res. 1996 Dec;2(12):2015-22.

46.

Increased apoptosis accompanies neoplastic development in the human colorectum.

Sinicrope FA, Roddey G, McDonnell TJ, Shen Y, Cleary KR, Stephens LC.

Clin Cancer Res. 1996 Dec;2(12):1999-2006.

47.

Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma.

Kitadai Y, Ellis LM, Tucker SL, Greene GF, Bucana CD, Cleary KR, Takahashi Y, Tahara E, Fidler IJ.

Am J Pathol. 1996 Nov;149(5):1541-51.

48.

Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.

Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM.

Clin Cancer Res. 1996 Oct;2(10):1679-84.

49.

Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells.

Takahashi Y, Bucana CD, Liu W, Yoneda J, Kitadai Y, Cleary KR, Ellis LM.

J Natl Cancer Inst. 1996 Aug 21;88(16):1146-51.

PMID:
8757194
50.

The need for standardized pathologic staging of pancreaticoduodenectomy specimens.

Staley CA, Cleary KR, Abbruzzese JL, Lee JE, Ames FC, Fenoglio CJ, Evans DB.

Pancreas. 1996 May;12(4):373-80.

PMID:
8740405

Supplemental Content

Loading ...
Support Center